MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with E

Exemestane

Exemestane 25mg tablets

Compatible

Stability notes for Exemestane 25mg tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Aromasin 25mg tablets (Pfizer Ltd).

Suppliers (18) of Exemestane 25mg tablets
Aromasin 25mg tablets (CST Pharma Ltd)
Aromasin 25mg tablets (Pfizer Ltd)
Exemestane 25mg tablets (A A H Pharmaceuticals Ltd)
Exemestane 25mg tablets (Accord-UK Ltd)
Exemestane 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Exemestane 25mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Exemestane 25mg tablets (Kent Pharma (UK) Ltd)
Exemestane 25mg tablets (Medihealth (Northern) Ltd)
Exemestane 25mg tablets (Morningside Healthcare Ltd)
Exemestane 25mg tablets (Necessity Supplies Ltd)
Exemestane 25mg tablets (Novumgen Ltd)
Exemestane 25mg tablets (Pfizer Ltd)
Exemestane 25mg tablets (Phoenix Healthcare Distribution Ltd)
Exemestane 25mg tablets (Rivopharm (UK) Ltd)
Exemestane 25mg tablets (Rudipharm Ltd)
Exemestane 25mg tablets (Sigma Pharmaceuticals Plc)
Exemestane 25mg tablets (Viatris UK Healthcare Ltd)
Exemestane 25mg tablets (Zentiva Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.